Delphi Consensus Excessive Daytime Sleepiness in OSA
Study Details
Study Description
Brief Summary
The objective of this study is to generate expert consensus statements on the differential diagnosis, definition, and management of EDS in patients with OSA who are adequately treated with primary therapy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
A study will be performed using a modified Delphi process with an international expert panel to generate recommendation statements related to the differential diagnosis and management of patients with residual EDS in OSA (and relevant sub-topics) and to determine the level of agreement for each statement from the panel as a whole. The following topics will be covered:
-
EDS: definition, evaluation/assessment, and tools
-
Definitions of residual EDS in patients with OSA treated with primary OSA therapy
-
Practical recommendations
-
Management Consensus is achieved through iterative rounds of survey and revision to the statements until a pre-determined level of agreement is met (80% agreement).
Part 1: planning and evidence review
-
Series of planning sessions with co-chairs and faculty leads
-
Literature is reviewed/summarized
-
Initial statements will be developed based on evidence Recommendation statements on EDS in OSA will be formulated and rated according to level of agreement on a 5-point Likert scale.
Part 2: Survey to achieve consensus
-
Survey, based on the initial statements developed by faculty leads, will be developed to allow for vetting by full faculty group
-
At least 3 rounds of review (2 remote and 1 live [virtual]) will be held to achieve consensus on each topic of interest and finalize consensus statements
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Delphi panel The Delphi panel will include 10 international experts in sleep and respiratory medicine. Two panelists will serve as co-chairs and eight panelists will serve as section leads for the major topic areas throughout the process. A series of planning sessions will be conducted with the co-chairs and section leads prior to implementation of the survey. |
Outcome Measures
Primary Outcome Measures
- Consensus [6 months]
The level of agreement for all statements achieving consensus from the expert panel; consensus is predefined as ≥ 80% of the panel rating a given statement A+ or A.
Eligibility Criteria
Criteria
Inclusion Criteria:
- Members of the panel include experts in sleep and respiratory medicine in North American and Europe.
Exclusion Criteria:
- Panelists who were not able to commit to all rounds of the modified Delphi process will be excluded.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | King's College London | London | United Kingdom | SE1 7EH |
Sponsors and Collaborators
- King's College London
- Jazz Pharmaceuticals
Investigators
- Study Chair: Joerg Steier, PhD, King's College London (KCL), UK
- Study Chair: Atul Malhotra, MD, University of California San Diego (UCSD), USA
Study Documents (Full-Text)
None provided.More Information
Publications
- 2021 EDS in OSA Delphi V1.0